Osteoporosis-associated alteration in the signalling status of BMP-2 in human MSCs under adipogenic conditions

Journal of Cellular Biochemistry

Volumn 116, Issue 7, 2015, Pages 1267-1277

  Donoso, Oscar ^a   Pino, Ana María ^a   Seitz, Germán ^b   Osses, Nelson ^c   Rodríguez, J Pablo ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL DR SÓTERO DEL RÍO   (Chile)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE VALPARAÍSO   (Chile)

Author keywords

ADIPOGENESIS; BMP RECEPTOR TYPE IA; BMP 2; HUMAN MESENCHYMAL STEM CELLS; OSTEOPOROSIS

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC RECEPTOR 1A; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SMAD PROTEIN; SMAD1 PROTEIN; SMAD4 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; BMP2 PROTEIN, HUMAN;

ADIPOGENESIS; ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; MESENCHYMAL STEM CELL; OSTEOPOROSIS; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; STEM CELL CULTURE; WESTERN BLOTTING; CELL CULTURE; CELL NUCLEUS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; MIDDLE AGED; PATHOLOGY; POSTMENOPAUSE OSTEOPOROSIS;

ADIPOGENESIS; AGED; BONE MORPHOGENETIC PROTEIN 2; CELL NUCLEUS; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; SIGNAL TRANSDUCTION;

EID: 84929103652     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25082     Document Type: Article

References (47)

1. Ahrens M, Ankenbauer T, Schroder D, Hollnagel A, Mayer H, Gross G,. 1993. Expression of human bone morphogenetic proteins-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. DNA Cell Biol 12: 871-880.
2. Astudillo P, Ríos S, Pastenes L, Pino AM, Rodríguez JP,. 2008. Increased adipogenesis of osteoporotic human-Mesenchymal Stem Cells (MSCs) is characterized by impaired leptin action. J Cell Biochem 103: 1054-1065.
3. Baksh D, Song L, Tuan RS,. 2004. Adult mesenchymal stem cells: Characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 8 (3): 301-316.
4. Böttcher Y, Unbehauen H, Klöting N, Ruschke K, Körner A, Schleinitz D, Tönjes A, Enigk B, Wolf S, Dietrich K, Koriath M, Scholz GH, Tseng YH, Dietrich A, Schön MR, Kiess W, Stumvoll M, Blüher M, Kovacs P,. 2009. Adipose tissue expression and genetic variants of the bone morphogenetic protein receptor 1A gene (BMPR1A) are associated with human obesity. Diabetes 58 (9): 2119-2128.
5. Bowers RR, Lane MD,. 2007. A role for bone morphogenetic protein-4 in adipocyte development. Cell Cycle 6 (4): 385-389.
6. Celil AB, Hollinger JO, Campbell PG,. 2005. Osx transcriptional regulation is mediated by additional pathways to BMP2/Smad signaling. J Cell Biochem 95: 518-528.
7. Chan GK, Deckelbaum RA, Bolivar I, Goltzman D, Karaplis AC,. 2001. PTHrP inhibits adipocyte differentiation by down-regulating PPAR gamma activity via a MAPKdependent pathway. Endocrinology 142: 4900-4909.
8. Chen D, Ji X, Harris MA, Feng JQ, Karsenty G, Celeste AJ, Rosen V, Mundy GR, Harris SE,. 1998. Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J Cell Biol 142: 295-305.
9. Consensus Development Conference,. 1993. Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 94: 646-650.
10. Dimitriou R, Tsiridis E, Giannoudis PV,. 2005. Current concepts of molecular aspects of bone healing. Injury 36: 1392-1404.
11. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G,. 1997. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89: 747-754.
12. Gautschi OP, Frey SP, Zellweger R,. 2007. Bone morphogenetic proteins in clinical applications. Aust NZ J Surg 77: 626-631.
13. Gerstenfeld LC, Cullinane DM, Barnes GL, Graves DT, Einhorn TA,. 2003. Fracture healing as a postnatal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 88: 873-884.
14. Giannoudis PV, Schneider E,. 2006. Principles of fixation of osteoporotic fractures. J Bone Joint Surg Br 88: 1272-1278.
15. Gimble JM, Morgan C, Kelly K, Wu X, Dandapani V, Wang CS, Rosen V,. 1995. Bone morphogenetic proteins inhibit adipocyte differentiation by bone marrow stromal cells. J Cell Biochem 58: 393-402.
16. Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, Aro H, Atar D, Bishay M, Börner MG, Chiron P, Choong P, Cinats J, Courtenay B, Feibel R, Geulette B, Gravel C, Haas N, Raschke M, Hammacher E, van der Velde D, Hardy P, Holt M, Josten C, Ketterl RL, Lindeque B, Lob G, Mathevon H, McCoy G, Marsh D, Miller R, Munting E, Oevre S, Nordsletten L, Patel A, Pohl A, Rennie W, Reynders P, Rommens PM, Rondia J, Rossouw WC, Daneel PJ, Ruff S, Rüter A, Santavirta S, Schildhauer TA, Gekle C, Schnettler R, Segal D, Seiler H, Snowdowne RB, Stapert J, Taglang G, Verdonk R, Vogels L, Weckbach A, Wentzensen A, Wisniewski T,. 2002. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: A prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 84: 2123-2134.
17. Haiyan H, Tan-Jing S, Li X, Hu L, He Q, Liu M, Lane MD, Tang QQ,. 2009. BMP signaling pathway is required for commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage. Proc Natl Acad Sci USA 106: 12670-12675.
18. Hu E, Kim JB, Sarraf P, Spiegelman BM,. 1996. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science 274: 2100-2103.
19. Kang Q, Song W-X, Luo Q, Tang N, Luo J, Luo X, Chen J, Bi Y, He B-C, Park JK, Jiang W, Tang Y, Huang J, Su Y, Zhu G-H, He Y, Yin H, Hu Z, Wang Y, Chen L, Zuo G-W, Shen XPJ, Vokes T, Reid RR, Haydon RC, Luu HH, Chuan He,. 2009. A Comprehensive analysis of the dual roles of BMPs In regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells end Development 18 (4): 545-558.
20. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP,. 1997. Osteogenic differentiation of purified culture-explanded human mesenchymal stem cells in vitro. J Cell Biochem 64: 295-312.
21. Karsenty G,. 2001. Minireview: Transcriptional control of osteoblast differentiation. Endocrinology 142: 2731-2733.
22. Kirkland JL, Tchkonia T, Pirtskhalava T, Han J, Karagiannides I,. 2002. Adipogenesis and aging: Does aging make fat go MAD? Exp Gerontol 37: 757-767.
23. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T,. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755-764.
24. Lavery K, Swain P, Falb D, Alaoui-Ismaili MH,. 2008. BMP-2/4 and BMP-6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. J Biol Chem 283: 20948-20958.
25. Lecka-Czernik B, Grinnell SJ, Moerman EJ, Cao X, Manolagas SC, O' Brien,. 1999. Identification of a Smad binding element in the PPARg2 promoter: A potential site of cross-talk between osteoblastogenesis and adipogenesis signaling pathways. J Bone Miner Res 14: Suppl1, S1056.
26. Lee KS, Hong SH, Bae SC,. 2002. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein. Oncogene 21: 7156-7163.
27. Miyazono K, Maeda S, Imamura T,. 2005. BMP receptor signaling: Transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev 16: 251-263.
28. Muruganandan S, Roman AA, Sinal CJ,. 2009. Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: Cross talk with the osteoblastogenic program. Cell Mol Life Sci 66: 236-253.
29. Nikolaou VS, Efstathopoulos N, Kontakis G, Kanakaris NK, iannoudis G,. 2009. The influence of osteoporosis in femoral fracture healing time. Injury 40: 663-668.
30. Nohe A, Keating E, Knaus P, Petersen NO,. 2004. Signal transduction of bone morphogenetic protein receptors. Cell Signal 16 (3): 291-299.
31. Osyczka A, Leboy P,. 2005. Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signalling. Endocrinology 146 (8): 3428-3437.
32. Pino AM, Rios S, Astudillo P, Fernández M, Figueroa P, Seitz G, Rodríguez JP,. 2010. Concentration of adipogenic and pro inflammatory cytokines in the bone marrow supernatant fluid of osteoporotic women. J Bone Min Res 25: 492-498.
33. Prall WC, Haasters F, Heggebö J, Polzer H, Schwarz C, Gassner C, Grote S, Anz D, Jäger M, Mutschler W, Schieker M,. 2013. Mesenchymal stem cells from osteoporotic patients feature impaired signal transduction but sustained osteoinduction in response to BMP-2 stimulation. Biochem Biophys Res Commun 440 (4): 617-622.
34. Raisz LG,. 1997. The osteoporosis revolution. Ann Intern Med 126: 458-462.
35. Reginato MJ, Krakow SL, Bailey ST, Lazar MA,. 1998. Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferators-activated receptor gamma. J Biol Chem 273: 1855-1858.
36. Rodríguez JP, Garat S, Gajardo H, Pino AM, Seitz G,. 1999. Abnormal osteogenesis in osteoporotic patients is reflected by altered mesenchymal stem cell dynamics. J Cell Biochem 75: 414-423.
37. Rodríguez JP, Rosen CJ, Pino AM,. 2012. In osteoporosis, differentiation of mesenchymal stem cells (MSCs) improves bone marrow adipogenesis. Biol Res 45: 81-89.
38. Rosen CJ, Ackert-Bicknell C, Rodríguez JP, Pino AM,. 2009. Marrow fat and the bone micro-environment developmental, functional and pathological implications. Crit Rev in Eukaryot Gene Expr 19 (2): 109-124.
39. Rosen ED, Spiegelman BM,. 2001. PPARgamma: A nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 276: 37731-37734.
40. Shi Y, Massagué J,. 2003. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113 (6): 685-700.
41. Sottile V, Seuwen K,. 2000. Bone morphogenetic protein-2 stimulates adipogenic differentiation mesenchymal precursor cells in synergy with BRL 49653 (rosiglitazone). FEBS Lett 475: 201-204.
42. Stromsoe K,. 2004. Fracture fixation problems in osteoporosis. Injury 35 (2): 107-113.
43. Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM,. 1994. MPPAR gamma 2: Tissue-specific regulator of an adipocyte enhancer. Genes Dev 8: 1224-1234.
44. Vögelin E, Jones NF, Huang JI, Brekke JH, Lieberman JR,. 2005. Healing of a critical-sized defect in the rat femur with use of a vascularized periosteal flap, a biodegradable matrix, and bone morphogenetic protein. J Bone Joint Surg Am 87: 1323-1331.
45. Waite KJ, Floyd ZE, Arbour-Reily P, Stephens JM,. 2001. Interferon-g-induced regulation of peroxisome proliferators-activated receptor g and STATs in adipocytes. J Biol Chem 276: 7062-7068.
46. Wang EA, Israel DI, Kelly S, Luxenberg DP,. 1993. Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factors 9: 57-71.
47. Wang X, Goh CH, Li B,. 2007. P38 mitogen-activated protein kinase regulates osteoblast differentiation through osterix. Endocrinology 148: 1629-1637.